FLT3 and acute myeloid leukemia: Recent whole genome sequencing analyses provided new insights into the origin and clonal evolution of AML mutations: “initiating” driver mutations (as FLT3 ITD) are early events and are relevant to leukemogenesis and targeted therapy, while cooperating mutations occur later and contribute to disease progression [12].